Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

Conditions: Metabolic Dysfunction-associated Fatty Liver Disease; Cirrhosis Interventions: Drug: Pioglitazone metformin tablets; Drug: Other drugs; Other: Drug-free Sponsors: The Affiliated Hospital of Hangzhou Normal University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials